Cargando…

ECOA-8. Lung adenocarcinoma brain metastasis prediction using tumor DNA methylation profiling

INTRODUCTION: The development of brain metastases from primary cancer profoundly impacts patient prognosis. Up to one quarter of lung cancers develop brain metastases and subsequent median overall survival is one year. Although clinical factors do not reliably predict brain metastasis development, D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuccato, Jeffrey, Mamatjan, Yasin, Aldape, Kenneth, Zadeh, Gelareh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255415/ http://dx.doi.org/10.1093/noajnl/vdab070.008

Ejemplares similares

OTHR-09. IDENTIFYING EPIGENETIC SIGNATURES IN LUNG ADENOCARCINOMAS THAT PREDICT DEVELOPMENT OF BRAIN METASTASIS
por: Zuccato, Jeffrey, et al.
Publicado: (2019)

71. MGMT PROMOTER METHYLATION IS A PROGNOSTIC BIOMARKER IN EGFR MUTANT LUNG ADENOCARCINOMA WITH BRAIN METASTASES
por: Mamatjan, Yasin, et al.
Publicado: (2020)

BSCI-26. COMPARATIVE METHYLATION PROFILING OF EGFR MUTANT LUNG ADENOCARCINOMA AND PAIRED BRAIN METASTASIS
por: Mamatjan, Yasin, et al.
Publicado: (2019)

ECOA-10. Integrated genomic and clinical analysis of BRAF-mutated glioma in adults
por: Langat, Pinky, et al.
Publicado: (2021)

The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
por: Karimi, Shirin, et al.
Publicado: (2019)

ECOA-5. Integrative 3D spatial characterization of genomic and epigenomic intratumoral heterogeneity in glioblastoma
por: Mathur, Radhika, et al.
Publicado: (2021)

ECOA-9. Integration of molecular and methylation classifications yields three meningioma groups and suggests chromosome 1p loss may be critical to the aggressive group
por: Bayley, James, et al.
Publicado: (2021)

ECOA-3. MLL4, UTX, and EZH2 regulate the expression of transcription factors associated with the epithelial-to-mesenchymal transition of lung cancer during metastasis to the brain at posttranscriptional steps
por: Kim, Young Zoon
Publicado: (2021)

ECOA-6. Genomic and transcriptomic analyses reveal diverse mechanisms responsible for deregulation of epigenetic enzyme/modifier expression in glioblastoma
por: Maleszewska, Marta, et al.
Publicado: (2021)

Introduction: Ongoing clinical challenges in the management of meningiomas and future directions
por: Wang, Justin Z, et al.
Publicado: (2023)

DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology
por: Pratt, Drew, et al.
Publicado: (2021)

Special issue: advances in the multimodality management of brain metastases and ongoing approaches to further improve their treatment
por: Zuccato, Jeffrey A, et al.
Publicado: (2021)

NGMA-1. Quantification of IDH mutant alleles predicts outcome in diffuse gliomas
por: Voisin, Mathew, et al.
Publicado: (2021)

Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
por: Karimi, Shirin, et al.
Publicado: (2020)

CORRELATION OF CLINICAL FEATURES TO DNA METHYLATION-BASED PROGNOSTIC SUBTYPES IN CHORODOMA PATIENTS
por: Ajisebutu, Andrew, et al.
Publicado: (2023)

BSCI-02 CSF PROTEOMICS AS A MINIMALLY-INVASIVE STRATEGY FOR DISTINGUISHING BRAIN METASTASES FROM OTHER PRIMARY BRAIN MALIGNANCIES
por: Mansouri, Alireza, et al.
Publicado: (2022)

TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy
por: Wei, Qingxia, et al.
Publicado: (2021)

35. EVALUATING CSF CIRCULATING TUMOR DNA IN INTRAPARENCHYMAL BRAIN METASTASIS
por: Cheok, Stephanie, et al.
Publicado: (2020)

MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021)

METABOLOGENOMIC CHARACTERIZATION UNCOVERS HETEROGENEITY AMONG IDH MUTANT GLIOMAS
por: Ajisebutu, Andrew, et al.
Publicado: (2023)

MMAP-09 CHARACTERISTICS CORRELATING WITH SURVIVAL IN PATIENTS TREATED FOR LARGE BRAIN METASTASES
por: Gutierrez-Valencia, Enrique, et al.
Publicado: (2022)

BSCI-05. ABL2-HSF1-E2F signaling axis promotes lung adenocarcinoma brain metastasis
por: Pendergast, Ann Marie, et al.
Publicado: (2021)

OMRT-9. Effect of Pre-Operative Stereotactic Radiosurgery on Brain Metastasis: Analysis of DNA and RNA Genomic Profiles from Phase-II Clinical Trial NCT03398694
por: Shireman, Jack, et al.
Publicado: (2021)

Clinical value of methylation testing: a case report of intraventricular schwannomas with associated molecular findings
por: Wang, Justin Z, et al.
Publicado: (2020)

44. EFFECT OF STEREOTACTIC RADIOSURGERY ON NON-SMALL CELL LUNG CANCER BRAIN METASTASIS: CONTINUED CORRELATIVE RADIOBIOLOGIC ANALYSIS OF DNA AND RNA GENOMIC PROFILES FROM PHASE-II CLINICAL TRIAL NCT03398694
por: Henriquez, Mario, et al.
Publicado: (2020)

Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology
por: Galldiks, Norbert, et al.
Publicado: (2021)

CLRM-20 IDENTIFYING RISK FACTORS AND ANALYZING SURVIVAL FOLLOWING PACHYMENINGEAL FAILURE
por: Kalyvas, Aristotelis, et al.
Publicado: (2022)

42. IDENTIFICATION OF BRAIN METASTASIS VULNERABILITIES USING METPLATFORM
por: Zhu, Lucía, et al.
Publicado: (2020)

DDRE-22. TARGETING SERINE SYNTHESIS IN BRAIN METASTASIS
por: Ngo, Bryan, et al.
Publicado: (2021)

Special issue: a contemporary landscape of the clinical and biological research in neurofibromatosis type 1
por: Suppiah, Suganth, et al.
Publicado: (2020)

61. EXPRESSION OF ANDROGEN RECEPTOR IN BREAST CANCER BRAIN METASTASIS
por: Qazi, Maleeha, et al.
Publicado: (2020)

39. CHARACTERIZING NOVEL INHIBITORS OF BRAIN METASTASIS-INITIATING CELLS
por: Kieliszek, Agata, et al.
Publicado: (2020)

OTHR-03. Brain Metastasis Among Ovarian Cancer Patients
por: Limon, Dror, et al.
Publicado: (2021)

A review of Central Nervous System Metastases: Diagnosis and Treatment, First Edition, 2020
por: Zuccato, Jeffrey A, et al.
Publicado: (2020)

Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of ODZ1 Gene Expression
por: Velásquez, Carlos, et al.
Publicado: (2019)

BSCI-19. Therapeutic intervention of lung-, breast-, and melanoma-brain metastasis
por: Kieliszek, Agata, et al.
Publicado: (2021)

BSCI-01. Small RNAseq analysis of microRNAs in brain metastasis
por: Jancalek, Radim, et al.
Publicado: (2021)

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
por: Djuric, Ugljesa, et al.
Publicado: (2017)

29. ROLE OF AGE AND CNS MYELOID CELLS ON BREAST CANCER BRAIN METASTASIS
por: Lai Wu, Alex Man, et al.
Publicado: (2020)

FSMP-03. INVESTIGATING CO-OPTED ASTROCYTIC METABOLISM IN MELANOMA BRAIN METASTASIS
por: Farnan, Julia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amkkjqbiff22e29enal1k19ggq